Respir Care:胸腔引流管对机械通气继发性气胸的影响和预测指标

2014-02-17 小哲 医学论坛网

这是一项回顾性观察研究,它收集了自2004年12月到2011年12月106位因为气胸而接受胸廓造口术使用呼吸机的患者。作者分析研究了61位受试者的63个事件。受试者被分成长期放置胸腔引流管胸管组和非长期放置胸腔引流管组。 长期放置组患者ICU死亡率高、住ICU天数长、住院天数长、气胸后上机天数长、吸气峰压高、肺气肿外科治疗的比率高。经过多变量回归分析,吸气峰压高和外科治疗肺气肿的比率高是

这是一项回顾性观察研究,它收集了自2004年12月到2011年12月106位因为气胸而接受胸廓造口术使用呼吸机的患者。作者分析研究了61位受试者的63个事件。受试者被分成长期放置胸腔引流管胸管组和非长期放置胸腔引流管组。【原文下载

长期放置组患者ICU死亡率高、住ICU天数长、住院天数长、气胸后上机天数长、吸气峰压高、肺气肿外科治疗的比率高。经过多变量回归分析,吸气峰压高和外科治疗肺气肿的比率高是长期放置胸腔引流管的独立预测因子。和无任何危险因素的病人组比较,高吸气峰压和肺气肿外科治疗的病人在28天内移除胸腔引流管的比例明显较低。

结论:高吸气峰压和肺气肿手术治疗是长期放置胸腔引流管的独立预测因子,对病人的临床预后有负面影响。

Dean Hess 博士的评论

这项研究为胸腔引流管的管理提供了更多的信息。令人感兴趣的是作者发现高吸气峰压和肺气肿手术治疗是长期放置胸腔引流管的独立预测因子,对病人的临床预后有负面影响。

原始出处

Kao JH, Kao HK, Chen YW, Yu WK, Pan SW, Wang JH, Lien TC, Ho LI, Kou YR.Impact and predictors of prolonged chest tube duration in mechanically ventilated patients with acquired pneumothorax.Respir Care. 2013 Dec;【原文下载


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952645, encodeId=919c195264504, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 28 15:13:00 CST 2014, time=2014-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724415, encodeId=f0481e2441562, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Jun 23 21:13:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406987, encodeId=d547140698eab, content=<a href='/topic/show?id=fa7c100231a5' target=_blank style='color:#2F92EE;'>#预测指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100231, encryptionId=fa7c100231a5, topicName=预测指标)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c72588657, createdName=anminleiryan, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441829, encodeId=99f314418290b, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
    2014-06-28 xzw113
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952645, encodeId=919c195264504, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 28 15:13:00 CST 2014, time=2014-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724415, encodeId=f0481e2441562, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Jun 23 21:13:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406987, encodeId=d547140698eab, content=<a href='/topic/show?id=fa7c100231a5' target=_blank style='color:#2F92EE;'>#预测指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100231, encryptionId=fa7c100231a5, topicName=预测指标)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c72588657, createdName=anminleiryan, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441829, encodeId=99f314418290b, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
    2014-06-23 feifers
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952645, encodeId=919c195264504, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 28 15:13:00 CST 2014, time=2014-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724415, encodeId=f0481e2441562, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Jun 23 21:13:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406987, encodeId=d547140698eab, content=<a href='/topic/show?id=fa7c100231a5' target=_blank style='color:#2F92EE;'>#预测指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100231, encryptionId=fa7c100231a5, topicName=预测指标)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c72588657, createdName=anminleiryan, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441829, encodeId=99f314418290b, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1952645, encodeId=919c195264504, content=<a href='/topic/show?id=a37ce8961a1' target=_blank style='color:#2F92EE;'>#继发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78961, encryptionId=a37ce8961a1, topicName=继发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Sat Jun 28 15:13:00 CST 2014, time=2014-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1724415, encodeId=f0481e2441562, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Jun 23 21:13:00 CST 2014, time=2014-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406987, encodeId=d547140698eab, content=<a href='/topic/show?id=fa7c100231a5' target=_blank style='color:#2F92EE;'>#预测指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100231, encryptionId=fa7c100231a5, topicName=预测指标)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10c72588657, createdName=anminleiryan, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441829, encodeId=99f314418290b, content=<a href='/topic/show?id=ee95638550d' target=_blank style='color:#2F92EE;'>#气胸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63855, encryptionId=ee95638550d, topicName=气胸)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0f4898732, createdName=12498c32m69暂无昵称, createdTime=Wed Feb 19 06:13:00 CST 2014, time=2014-02-19, status=1, ipAttribution=)]